0
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Angiogenesis and Histologic Scoring in Prostatic Carcinoma—A Valuable Cost Effective Prognostic Indicator

, , , &
Pages 139-143 | Received 14 Jun 2004, Accepted 30 Jul 2004, Published online: 16 Jul 2015
 

Abstract

Objective: To find any correlation between microscopic angiogenesis grading system (MAGS) score and Gleason score and serum prostate specific antigen (S.PSA) in carcinoma of prostate.

Study design: Examination of 30 patients with prostatic carcinoma compared with an age matched control group of 30 patients having histopathologically proven benign prostatic Hyperplasia. The Preoperative serum PSA level was determined in all patients. Histopathological examination for MAGS score was done in all patients and Gleason scoring was done for cases of prostatic carcinoma.

Result: MAGS score had a definite correlation with Gleason score (Correlation coefficient, ). Studying the relationship between MAGS score and S.PSA, a statistically significant difference is found between S.PSA levels in study and control groups, and in the three MAGS score groups namely 21–30, 31–40 and 41–50.

Conclusion: Gleason score and MAGS score are well related to each other. As tumor becomes more poorly differentiated with rising Gleason score, it would also have increased number of capillaries and higher grade endothelial cytology leading to a higher MAGS score.

Acknowledgements

We are immensely grateful to Dr Zubair for his untiring help in the preparation of this manuscript. Our deepest gratitude goes to Dr R.N. Mishra of the Department of Biostatistics, without whose help the project would have been impossible.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.